JSJerzy B. Starzyk

Jerzy B. Starzyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jerzy B. Starzyk has a total of 102 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aggrecanopathy as an Underrecognized Cause of Idiopathic Short Stature: The Importance of Early Genetic Confirmation for Timely Diagnosis and Management—Case Reports and Literature Review

    by Aleksandra Sosin, Tetiana Tkachuk, Aleksandra Furtak, Magdalena Janeczko, Karol Stożek, Teofila Książek, Helena Poławska, Damian Loska, Sebastian Wardak, Jerzy Starzyk, et al.

    Background: Short stature is a frequent clinical problem with a broad differential diagnosis. Emerging evidence indicates that pathogenic variants in the ACAN gene represent an underrecognized cause of growth failure and are often misclassified as idiopathic short stature. Case presentation: We report two pediatric patients harboring pathogenic ACAN gene variants, both presenting with short stature and distinctive facial dysmorphism. The first patient, a 15-year-old boy, exhibited short stature, advanced bone age, and a characteristic facial gestalt, including ptosis, hypertelorism, down-slanting palpebral fissures, and fleshy auricles, features not previously described in association with aggrecanopathy. Genetic analysis revealed a novel heterozygous frameshift variant, c.5677_5684del (p.Glu1893TrpfsTer8), in exon 12 of the ACAN gene. The second patient, a 5.5-year-old girl, presented with short stature, mild facial dysmorphism (down-slanting palpebral fissures and retracted mandible), and feeding difficulties. Copy number variation analysis identified a heterozygous deletion encompassing exons 15–19 of the ACAN gene. In both patients, the endocrine evaluation was unremarkable, and no chronic systemic disease was identified. The genetic findings were concordant with the clinical phenotype, confirming aggrecanopathy as the underlying cause of growth failure. Conclusions: These cases further delineate the phenotypic spectrum of ACAN-related short stature and underscore the diagnostic value of genetic testing in children with unexplained or idiopathic growth failure. Importantly, we expand the dysmorphological phenotype of aggrecanopathy by describing previously unreported facial features, which may facilitate earlier clinical recognition and diagnosis. The timely identification of pathogenic variants in the ACAN gene may have significant implications for patient management and long-term outcomes.


  • Investigating vitamin B12 levels in children with obesity: the role of metformin

    by A. Iwańska, D. Goncerz, M. Ahmed, R. Aoun, A. Kozioł-Kozakowska, E. Szczudlik, A. StęPniewska, M. Wójcik, J. B. Starzyk

    Aim To assess vitamin B12 levels in children with obesity and analyze the association with obesity severity, complications and treatment methods. Methods A retrospective analysis of data of 500 patients with obesity (51.6% boys) was performed, mean age was 13.1 years (range 1.7–17.9), mean BMI Z-score was 2.17 (SD 0.42). Anthropometric data, body composition, blood pressure, lipid profile, glycated hemoglobin and liver enzymes were evaluated. Statistical analysis included Spearman correlation and Mann–Whitney U test (α = 0.05). Results Dyslipidemia was found in 45.8%, hypertension in 14.8%, elevated liver enzymes in 19.8%. 12% received metformin. Median B12 was 407 pg/ml (range: 161–1168). No correlation was found between B12 and BMI Z-score, body fat percentage, high-density lipoprotein, triglycerides, gamma-glutamyl transferase or glycated hemoglobin. Negative correlation was found with creatinine (p < 0.001) and homeostatic model assessment for insulin resistance (p < 0.001); positive correlation was found with total cholesterol (p = 0.012), low-density lipoprotein (p = 0.029), alanine aminotransferase (p = 0.002) and aspartate aminotransferase (p < 0.001). Metformin users showed significantly lower B12 (398 vs 410 pg/ml, p = 0.043). Conclusion: Children with obesity do not exhibit vitamin B12 deficiency. Obesity severity is not associated with B12 changes. Insulin resistance (especially metformin-treated) may be associated with reduced B12 levels. Pediatric patients with uncomplicated obesity do not require regular vitamin B12 monitoring, whereas it appears necessary in patients on metformin therapy. What is Known – What is New: • The limited literature on vitamin B12 levels in children with obesity reports a negative correlation with obesity severity which is inconsistent with observations from our center performing metabolic assessments on over 500 children with obesity annually. • Our study demonstrates that children with obesity do not exhibit vitamin B12 deficiency and obesity severity is not associated with B12 changes. However, metformin treatment may be associated with reduced B12 levels. • Pediatric patients with uncomplicated obesity do not require regular vitamin B12 monitoring, whereas it appears reasonable in patients on metformin therapy.


  • Open Access

    Positive influence of long-term growth hormone therapy on circulating stem cells in pediatric patients with growth hormone deficiency

    by Anna Wędrychowicz, Katarzyna Sielatycka, Magda Kucia, Ewa Kubiś, Dorota Roztoczyńska, Jerzy B. Starzyk

    Very small embryonic/epiblast‐like stem cells (VSELs), present in circulating blood, are small, non-hematopoietic cells that express markers of pluripotent embryonic and primordial germ cells. VSELs are believed to contribute to postnatal tissue and organ regeneration. We report the first long-term observation of VSELs in response to growth hormone (GH) therapy in pediatric patients. Twenty patients aged 5.2–13.4 years with GH-deficiency were monitored periodically during the first year of GH treatment. Eight of these patients were re-examined after eight years of continuous therapy. Selected stem cell populations were analyzed in peripheral blood using flow cytometry. Long-term GH therapy resulted in increased numbers of CD34 + VSELs, while CD133 + VSELs remained comparable to baseline. The increase in VSELs was accompanied by parallel increases in circulating hematopoietic stem cells, mesenchymal stromal cells (MSCs), and endothelial progenitor cells. We observed significant positive correlations between VSELs and MSCs, and between CD34 + VSELs and MSCs with postprandial glucose levels. These data suggest that VSELs are responsive to GH treatment. Long-term GH therapy appears to modulate VSEL populations without causing harm and may even enhance them in GH-deficient patients. Unlike findings in experimental animals, GH therapy in humans did not show adverse effects on lifespan or organ function.

  • Open Access

    Occult Thyroid Cancer in Autoimmune Thyroiditis: Lymph Node Ultrasound as the Sole Diagnostic Indicator of Malignancy in a Pediatric Case of Papillary Thyroid Carcinoma

    by Maria Szwarkowska, Konrad Kaleta, Aleksandra Jurek, Monika Kujdowicz, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Marcin Maślanka, Wojciech Górecki, Jerzy Starzyk, Dominika Januś

    Background: Autoimmune thyroiditis (AIT) is a common thyroid disorder in children, linked to an increased risk of papillary thyroid carcinoma (PTC). Characteristic ultrasonographic features of AIT can obscure PTC, delaying diagnosis. Case Presentation: An 11-year-old girl with a two-year history of AIT presented with persistently elevated thyroid-stimulating hormone (TSH) levels despite levothyroxine therapy. Examination revealed a firm, slightly enlarged right thyroid lobe. Serial thyroid ultrasounds showed typical AIT features, with no apparent tumor. However, a cervical lymph node ultrasound detected a suspicious lymph node with pathological vascularization. Fine-needle aspiration suggested possible PTC metastasis. The patient underwent total thyroidectomy with central and right lateral neck dissection. Histopathology confirmed multifocal PTC with cervical lymph node metastases (pT3aN1bM0). Postoperative radioactive iodine therapy resulted in undetectable thyroglobulin levels, indicating a biochemical response. Conclusions: Children with AIT may harbor occult PTC even without thyroid gland abnormalities suggestive of malignancy. Comprehensive ultrasound evaluation, including cervical lymph nodes, is vital for early detection and timely treatment.


  • Open Access

    Occult Thyroid Cancer in Autoimmune Thyroiditis: Lymph Node Ultrasound as the Sole Diagnostic Indicator of Malignancy in a Pediatric Case of Papillary Thyroid Carcinoma

    by Maria Szwarkowska, Konrad Kaleta, Aleksandra Jurek, Monika Kujdowicz, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Marcin Maślanka, Wojciech Górecki, Jerzy B. Starzyk, Dominika Januś

    Background: Autoimmune thyroiditis (AIT) is a common thyroid disorder in children, linked to an increased risk of papillary thyroid carcinoma (PTC). AIT's characteristic ultraso-nographic features can obscure PTC, delaying diagnosis. Case Presentation: An 11-year-old girl with a two-year history of AIT presented with persistently elevated thyroid-stimulating hormone (TSH) levels despite levothyroxine therapy. Examination revealed a firm, slightly enlarged right thyroid lobe. Serial thyroid ultrasounds showed typical AIT features, with no apparent tumor. However, cervical lymph node ultrasound detected a suspicious lymph node with pathological vascularization. Fine-needle aspiration suggested possible PTC metastasis. The patient underwent total thyroidectomy with central and right lateral neck dissection. Histopathology confirmed mul-tifocal PTC with cervical lymph node metastases (pT3aN1bM0). Postoperative radioactive iodine therapy resulted in undetectable thyroglobulin levels, indicating biochemical response. Conclusion: Children with AIT may harbor occult PTC even without thyroid gland abnormalities suggestive of malignancy. Comprehensive ultrasound evaluation, including cervical lymph nodes, is vital for early detection and timely treatment.

  • Open Access

    Severe Hypocalcemia Dependent on Fluconazole in a Newborn With Barakat Syndrome

    by Dorota Roztoczyńska, Anna Wędrychowicz, Magdalena Ossowska, Aleksandra Furtak, Paulina Miśkiewicz-Stanek, Ewelina Preizner-Rzucidło, Joanna Kwinta-Rybicka, Mateusz Jagła, Jerzy B. Starzyk

    We present a case of a newborn with Barakat syndrome, characterized by congenital hypoparathyroidism, severe hypocalcemia, recurrent urinary tract infections (UTIs), and congenital candidiasis, which is an atypical feature for this syndrome. The patient, born at term, exhibited dysmorphia, hearing loss, and renal dysfunction. Genetic testing revealed a novel, de novo GATA3 variant. Fluconazole, introduced to treat recurrent UTIs and congenital candidiasis, unexpectedly played a crucial role in normalizing calcium levels. This effect may be attributed to fluconazole’s influence on the metabolism of vitamin D, potentially enhancing calcium absorption and reabsorption. The normalization of calcium levels in this patient emphasizes the complex interplay between antifungal therapy and calcium homeostasis, particularly in patients with congenital hypoparathyroidism. This case highlights the importance of genetic testing in diagnosing neonatal hypocalcemia and illustrates the potential for fluconazole to impact calcium metabolism in Barakat syndrome. A multidisciplinary approach, including immunological, nephrological, and otolaryngological evaluations, is essential for comprehensive long‐term care.

  • Open Access

    Long‐Term Consequences of Misdiagnosis of Parathyroid Adenomas in Pediatric Patients

    by Dorota Roztoczyńska, Aleksander Konturek, Anna Wędrychowicz, Magdalena Ossowska, Alicja Kapusta, Anna Taczanowska-Niemczuk, Jerzy B. Starzyk

    Primary hyperparathyroidism (PHPT) is rare in children but exhibits a more dynamic course than in adults, often leading to multiorgan complications if diagnosis is delayed. This article aims to highlight diagnostic challenges of parathyroid adenomas in children and discuss associated complications from delayed diagnosis. Three boys, aged 15.5, 10, and 16 years, were retrospectively analyzed for hypercalcemia. The diagnosis was based on biochemical and hormonal tests, as well as imaging studies (ultrasound, scintigraphy, and densitometry). The mean diagnosis delay was 20 months (9–35). All boys experienced appetite loss and bone symptoms. Patient 1 was initially misdiagnosed with slipped capital femoral epiphysis (SCFE) and underwent orthopedic surgery without recognition of severe hypercalcemia. Patient 2 was misdiagnosed with vasopressin deficiency following a tibia fracture. Patient 3’s symptoms were attributed to stress. All patients had parathyroid adenomas, but Patients 2 and 3 had an ectopic thymus location. Following adenoma excision, Patients 2 and 3 developed hypocalcemia, the lasting consequences of which included nephrocalcinosis and low bone mass; Patient 3 also developed hypertension and depression. Conclusions: (1) any child presenting symptoms such as loss of appetite, abdominal pain, weight loss, depression, or bone abnormalities must urgently have serum calcium levels assessed to exclude PHPT. (2) Delayed diagnosis of PHPT in children is dangerous, as it leads to irreversible organ damage, including severe bone loss, nephrocalcinosis, and hypertension. (3) Comprehensive hormonal and genetic evaluation prior to surgery is essential, along with prompt correction of hypocalcemia to minimize complications and improve treatment outcomes. (4) After parathyroid adenoma removal, intensive calcium and vitamin D supplementation is required to prevent hungry bone syndrome and support proper bone recovery. (5) Due to the significant risk of disease recurrence, children with PHPT require long‐term endocrine follow‐up and thorough genetic testing, enabling early detection of relapse and timely intervention.


  • Open Access

    Primary Adrenal Insufficiency, Complete Sex Reversal, and Unique Clinical Phenotype in a Patient with Severe CYP11A1 (P450scc) Deficiency—Case Report and Literature Overview

    by Zuzanna Nowak, Ewelina Preizner-Rzucidło, Jakub Gawlik, Jerzy B. Starzyk, Dominika Januś

    Background: Congenital adrenal hyperplasia (CAH) is a group of genetic disorders that lead to the dysfunction of the steroidogenesis pathway, resulting in steroid hormone deficiency of varied intensity. The cholesterol side-chain cleavage enzyme (P450scc), coded by the CYP11A1 gene, is vital to the first step in the biosynthesis of steroid hormones, which is the conversion of cholesterol to pregnenolone. Therefore, its deficiency causes a general steroid hormone shortage. Objective: We report a case of CAH caused by P450scc deficiency with complete 46, XY sex reversal, characteristic facial features (narrow middle section of the face, small ears with thick helix, fleshy upturned lobules), and dysmorphic macrocephaly along with shortened upper and lower extremities. Results: Our patient carries a compound heterozygotic pathogenic variant of the CYP11A1 gene, with two frameshift pathogenic variants NM_000781.3(CYP11A1):c.358del (p.Arg120Aspfs*18) in exon 2 and NM_000781.3(CYP11A1):c.835del (p.Ile279Tyrfs*10) in exon 5. To date, only around 50 cases with CYP11A1 pathogenic variants have been reported worldwide. We believe this is the first described case of a newborn with severe, classic P450scc deficiency in Poland. Conclusions: CYP11A1 (P450scc) deficiency is a rare and complex disorder that leads to primary adrenal insufficiency and may present with 46, XY disorders of sex development (DSD), phenotypic variations, and associated endocrinological abnormalities. This case, along with others cited, highlights the diverse presentations of DSD in individuals with pathogenic CYP11A1 variants. Optimal management necessitates a multidisciplinary approach by a specialized DSD team. Gonadectomy is a key consideration to decrease the teratogenic risk associated with intra-abdominal gonadal tissue.


  • Open Access

    Ultrasound–Histopathological Presentation of Thyroid and Ovary Lesions in Adolescent Patients with DICER1 Syndrome: Case Reports and Literature Overview

    by Dominika Januś, Monika Kujdowicz, Konrad Kaleta, Kamil Możdżeń, Jan Radliński, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Marcin Maślanka, Wojciech Górecki, Jerzy B. Starzyk

    Background: DICER1, a cancer predisposition syndrome (CPS), seems to escape timely diagnosis in pediatric patients. Case report 1: A 16-year-old female patient was referred to the endocrinology ward due to a large goiter. Her medical history indicated normal sexual maturation, with menarche occurring at 13.5 years. Over the past 2.5 years, she had developed pronounced androgenic symptoms, including a deepened male voice; facial, back, and neckline acne; hirsutism; and menstrual irregularities leading to secondary amenorrhea. A thyroid ultrasound identified a multinodular goiter (MNG) with cystic–solid lesions containing calcifications. An abdominal ultrasound identified a 5.7 × 6.9 cm solid mass in the right adnexal region, displacing the uterus to the left. Histopathological examination confirmed a Sertoli–Leydig cell tumor. The patient was subjected to a total thyroidectomy. Histopathology revealed benign follicular cell-derived neoplasms. Thyroid follicular nodular disease (TFND) was diagnosed bilaterally. DNA analysis using NGS, confirmed via the Sanger method, revealed a pathogenic heterozygotic variant c.2953C>T [p.Gln985*] in exon 18 of the DICER1 gene. Case report 2: A 12-year-old male patient was admitted to the pediatric surgery unit due to a 33 mL goiter. A month prior to his admission, the patient discovered a palpable nodule in his neck, accompanied by hoarseness. An ultrasound revealed MNG. Molecular analysis revealed a pathogenic heterozygotic variant c.2782C>T [p.Gln928*] in exon 17 of the DICER1 gene. Subsequently, a total thyroidectomy was performed, and histopathological examination revealed TFND bilaterally. Conclusions: Recent advances in genetic evaluation and in histological approaches indicate that MNG/TFND, although rare in the pediatric population, when accompanied by characteristic ultrasound and histopathological features, and by additional features such as androgenization, may warrant assessment also of the DICER1 gene within CPS molecular panel screening.


  • Open Access

    Reversibility of Hyperglycemic States in Children with Obesity-Diagnostic Pitfalls in the Assessment of Glucose Metabolism in Children and Adolescents with Obesity

    by Anna Iwanskka, Malgorzata Wójcik, Ewa Szczudlik, Anna Stepniewska, Jerzy B. Starzyk

    Objective: Disorders of glucose metabolism in children with obesity are less common than in adults. There is also evidence that they may be transient. The aims of this study were to determine the prevalences of impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and type 2 diabetes mellitus (DM2) and its reversibility in pediatric patients with obesity and to define the factors determining the reversibility of prediabetes or progression to diabetes. Methods: Retrospective analysis included of young patients with obesity. Patients presented and were treated between 2000-2022 at a single center. Results: The study included 573 (316 girls; 55.15%) Caucasian patients with median body mass index (BMI) Z-score of 3.95 (range 2.09.9) and median age 13.9 (2.9-17.1) years old. OGTT results were normal in 90.8% (n=520) and signs of prediabetes occurred in 9.2% (n=53); IFG 17%, IGT 88.7%, DM 0%. Among those who underwent OGTT twice (n=53), impaired glucose regulation was present in 9.3% (n=5) (IFG 40%, IGT 80%, DM 0%) at baseline and in 14.8% subject (n=8) (IFG 25%, IGT 50%, DM 25%) at follow-up after lifestyle modification only. After 12-36 months of follow up, in those with a history of IGT, 60% reverted to normal glucose tolerance, while IFG and IGT persisted in 20% and 20%, respectively, and none progressed to DM. The risk factors for progression of glucose metabolism disorders were increase of BMI Z-score, higher insulin levels and elevated homeostatic model assessment-insulin resistance. Conclusion: IFG and IGT are common in pediatric patients with obesity, while the progression to DM2 is rare. Disorders of glucose metabolism have reversible character.